Popular Articles From: A Conservative ETF Portfolio for Retirees to Aeterna Zentaris Selects Charleston, S.C. as New Location for its North American Business and Global Commercial Operations


2011/04/12
See what we recommend for risk-averse ETF investors.
Sign-up for A Conservative ETF Portfolio for Retirees investment picks
2011/09/15
See what we recommend for risk-averse ETF investors.
Sign-up for A Conservative ETF Portfolio for Retirees investment picks
2012/08/30
This aggressively positioned portfolio illustrates how this increasingly popular strategy works.
Sign-up for A Sample Retirement Portfolio Using the Bucket Approach investment picks
2014/5/19
COO to Focus on Customer Service, Franchisee Profitability and Marketing HORSHAM, Pa.
Sign-up for AAMCO Transmissions Announces New Chief Operating Officer investment picks
ATLANTA , April 25, 2014 /PRNewswire/ -- Aaron's, Inc. (NYSE: AAN) , a leader in the sales and lease ownership and specialty retailing of residential furniture, consumer electronics, home appliances and accessories, today announced revenues and earnings for the three months ended March 31, 2014.
Sign-up for Aaron's, Inc. Reports First Quarter Results investment picks
- Reports First-Quarter Adjusted EPS of $0.71, Up 4.4 Percent and Above Previous Guidance Range of $0.67 to $0.69 (Reports GAAP EPS of $0.61) - Delivers First-Quarter Revenue of $4.563 Billion, an Increase of 5.4 Percent Over First-Quarter 2013 (Up 6.7 Percent On an Operational Basis) - Revenue Growth Reflects 17.5 Percent Global Reported Sales Growth from HUMIRA (Up 18.4 Percent On an Operational Basis) and Double-Digit Growth from Other Key Products - Delivers Significant Gross Margin Expansion and Strong Investment Spending in R&D and SG&A - Recently Submitted U.S. Regulatory Application for Interferon-Free HCV Combination; Continues to Expect U.S. Approval in 2014; EU Submission Planned for Early May - Pipeline Continues to Advance in 2014 With Numerous Data Milestones, Regulatory Submissions and Phase Transitions, Including Initiation of a Phase 3 Trial for Veliparib in Non-Small Cell Lung Cancer - Confirms 2014 Adjusted EPS Guidance Range of $3.00 to
Sign-up for AbbVie Reports First-Quarter 2014 Financial Results investment picks
2014/5/8
WASHINGTON , May 8, 2014 /PRNewswire/ -- Abengoa (MCE: ABG.B/P SM /NASDAQ: ABGB), the company that develops innovative technology solutions for sustainable development in the energy and environment sectors, today announced a change in the time at which it will release its financial results for the first quarter of 2014.
Sign-up for Abengoa announces a change in its earnings conference call time investment picks
2014/4/24
PHILADELPHIA , April 24, 2014 /PRNewswire/ -- Aberdeen Global Income Fund, Inc. (the "Fund") (NYSE MKT: FCO) , a closed-end bond fund, announced today its performance data and portfolio composition as of March 31, 2014 .
Sign-up for Aberdeen Global Income Fund, Inc. Announces Performance Data And Portfolio Composition investment picks
Founder of Boston-based Kerry Capital Advisors, Mr.
Sign-up for Accelerating Its Team-Building Momentum, Global Digital Solutions, Inc. Adds Thomas W. Janes, Leading Private Equity and Investment Banking Expert, to the Company's Advisory Board investment picks
SOUTH SAN FRANCISCO, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO) , a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections, today reported financial results for the quarter ended March 31, 2014.
Sign-up for Achaogen Announces First Quarter 2014 Results investment picks
- Dosing Initiated in Phase 1 Study to Evaluate the Safety, Tolerability and Antiviral Activity of ACH-3422, NS5B Uridine-Analog Nucleotide Prodrug - NEW HAVEN, Conn., April 30, 2014 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that is has begun dosing study participants with ACH-3422, Achillion's proprietary uridine-analog nucleotide inhibitor, in a Phase 1 clinical trial.
Sign-up for Achillion Advances ACH-3422, Uridine-Analog Nucleotide Inhibitor, Into Clinical Trial; Initiates Phase 2 Pilot Study With ACH-3102, NS5A Inhibitor, for HCV investment picks
SAN DIEGO and MORRISVILLE, N.C. , April 28, 2014 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) by Forest Laboratories, Inc. (NYSE: FRX) .
Sign-up for Acquisition of Furiex Pharmaceuticals, Inc. by Forest Laboratories, Inc. May Not Be in Shareholders' Best Interests investment picks
DUBLIN , May 12, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Valeant Pharmaceuticals International to settle all outstanding patent litigation related to Actavis' generic version of Acanya ® (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/2.5%. Acanya ® Gel is a lincosamide antibiotic and benzoyl peroxide indicated for the topical treatment of acne vulgaris.
Sign-up for Actavis Announces Acanya® Gel Patent Challenge Settlement investment picks
- First Quarter 2014 GAAP Earnings Per Diluted Share of $0.55 - - 86% Increase in First Quarter 2014 Adjusted EBITDA to $860 million - DUBLIN , April 30, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today reported net revenue increased 40 percent to $2.66 billion for the first quarter ended March 31, 2014 , compared to $1.90 billion in the first quarter 2013.
Sign-up for Actavis Net Revenue Increases 40% to $2.66 Billion in First Quarter 2014; Non-GAAP EPS Increases 75% to $3.49 investment picks
ZHUHAI, China , April 24, 2014 /PRNewswire/ -- Actions Semiconductor Co., Ltd.
Sign-up for Actions Semiconductor Files Annual Report on Form 20-F investment picks
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1112379&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Announces First Quarter 2014 Financial Results investment picks
Acxiom® Corporation (Nasdaq:ACXM) expects to issue its FY 2014 fourth quarter and full year earnings release on Wednesday, May 14, after the financial markets close.
Sign-up for Acxiom to Discuss Fourth Quarter Earnings investment picks
EMERYVILLE, Calif.
Sign-up for Adamas Reports First Quarter 2014 Financial Results investment picks
ROSELAND, N.J., April 10, 2014 (GLOBE NEWSWIRE) -- ADP ® (Nasdaq:ADP) , a leading global provider of Human Capital Management (HCM) solutions, today announced that the company's Board of Directors has approved a plan to separate the Dealer Services business into an independent publicly traded company through a tax-free spin-off of 100% of Dealer Services to ADP shareholders.
Sign-up for ADP Announces Plan for Spin-Off of Dealer Services Business investment picks
http://media.marketwire.com/attachments/201405/74917_advent.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1112434&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for Advent Wins at 2014 Family Wealth Report Awards investment picks
WINSTON-SALEM, N.C. , May 23, 2014 /PRNewswire/ -- Reynolds American Inc. (NYSE: RAI) has announced the following: "Reynolds American operating companies creating 200 N.C. jobs, investing in manufacturing equipment for VUSE digital vapor cigarette." Go to RAI's website, www.reynoldsamerican.com , to read the full release.
Sign-up for Advisory: RAI companies creating jobs, investing in equipment for VUSE digital vapor cigarette investment picks
WINSTON-SALEM, N.C. , May 6, 2014 /PRNewswire/ -- Reynolds American Inc. (NYSE: RAI) has announced the following: "RAI to webcast CEO's participation at Goldman Sachs summit on May 13 ." Go to RAI's website, www.reynoldsamerican.com , to read the full release.
Sign-up for Advisory: RAI to webcast CEO's participation at Goldman Sachs summit investment picks
2014/5/22
WINSTON-SALEM, N.C. , May 22, 2014 /PRNewswire/ -- R.J. Reynolds Tobacco Company has issued the following release: "R.J. Reynolds Tobacco Company announces sale of iconic Reynolds Building." Go to R.J. Reynolds' website, www.rjrt.com , or Reynolds American Inc.'s website, www.reynoldsamerican.com , to read the full release.
Sign-up for Advisory: R.J. Reynolds Tobacco Company announces sale of iconic Reynolds Building investment picks
Partners, Athletes and VIPs On-Hand to Celebrate New World-Class Arena LAS VEGAS , May 1, 2014 /PRNewswire/ -- Las Vegas Arena Company, owned by AEG and MGM Resorts International (NYSE: MGM) , broke ground today on a world-class, privately funded, $375 million indoor arena set to open in spring 2016.
Sign-up for AEG And MGM Resorts International Break Ground On New Las Vegas Arena Set To Debut In Spring 2016 investment picks
CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) , a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in Deutsche Bank 39 th Annual Health Care Conference in Boston.
Sign-up for Aegerion Pharmaceuticals Announces Webcast of Presentations at Upcoming Investor Conferences investment picks
KAUAI, Hawaii , May 21, 2014 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) , the U.S. Navy and the Missile Defense Agency successfully completed the first live fire test of Aegis Ashore, where the new land-based system safely launched and controlled a missile against a simulated target.
Sign-up for Aegis Ashore Achieves Major Test Milestone For Worldwide Ballistic Missile Defense System investment picks
2014/5/15
THE HAGUE, The Netherlands , May 15, 2014 /PRNewswire/ -- Solid business growth drives higher underlying earnings before tax Underlying earnings up 7% to EUR 498 million , driven by growth, higher equity markets and lower holding leverage cost, partly offset by unfavorable exchange rates Fair value items loss of EUR 116 million , mainly due to hedging programs without accounting match Net income up strongly to EUR 392 million Return on equity increases to 8.4% Strong sales growth driven by pensions, variable annuities and asset management Gross deposits up 35% to EUR 13.5 billion , driven by pensions and variable annuities in US and asset management; net deposits impacted by transfer of Polish pension assets and replacement of a large investment mandate Life sales down 8% to EUR 459 million ; growth in US more than offset by lower UK sales post-RDR Increase of 17% to
Sign-up for Aegon Delivers Strong Earnings and Sales Growth in Q1 2014 investment picks
2014/4/8
SACRAMENTO, Calif., April 8, 2014 (GLOBE NEWSWIRE) -- Aerojet Rocketdyne, a GenCorp (NYSE:GY) company, has been awarded a contract from the Flight Opportunities Program Office at Armstrong Flight Test Center to develop propulsion technology for miniature satellites that could possibly lower cost and accelerate mission schedules.
Sign-up for Aerojet Rocketdyne Awarded Contract to Develop Propulsion Technology for CubeSats investment picks
QUÉBEC CITY, May 5, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology, today announced that it has selected Charleston, South Carolina as its new location for the Company's North American business and global commercial operations.
Sign-up for Aeterna Zentaris Selects Charleston, S.C. as New Location for its North American Business and Global Commercial Operations investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: A Conservative ETF Portfolio for Retirees to Aeterna Zentaris Selects Charleston, S.C. as New Location for its North American Business and Global Commercial Operations
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry